Definitive Contract HT942525CE015
- Not listed
- <p>This is a $249,276.66 firm fixed-price purchase order awarded by the U.S. Department of Defense's (DoD) Medical Command to Puriolabs, LLC, a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of the "PURITALL MOBILE DESKTOP DEVICE STERILIZER" and has an ultimate completion date of October 24, 2022. The contract was set aside for total small business participation.</p>
- The Defense Health Agency has awarded a $1.95 million firm fixed-price contract to Lynntech Inc., a small business technology development company based in College Station, Texas, under the Small Business Innovation Research (SBIR) Program Phase II Action. The contract, designated as a total small business set-aside, is for the development of the FAR-Forward Austere Sterilizer (FAST) and carries a completion date of January 4, 2028. Lynntech will conduct research, development, and evaluation...
- TDA Research, Inc., a small business based in Golden, Colorado, received a $1.95 million Firm Fixed Price contract award from the Defense Health Agency on September 17, 2025, to develop a chemical sterilant solution for sterilizing surgical instruments and other materiel through immersion in austere environments. This Phase II Small Business Innovation Research (SBIR) award, designated as a total small business set-aside, will be performed in Golden, Colorado, with an ultimate completion date of...
- This federal contract award, valued at $1,097,326.95, was issued by the Defense Health Agency (DHA) to Polaris Sensor Technologies Inc., a woman-owned small business based in Huntsville, Alabama. The contract is for the DHA's Small Business Innovation Research (SBIR) Phase II program, specifically under Topic A11A-T026, and is titled "A Man-Portable Low Power Medical Sterilizer Using CleanSmoke." The contract has a firm-fixed-price pricing type and an ultimate completion date of May...
- The Defense Health Agency (DHA) awarded a $1.3 million firm fixed-price contract to Advanced Cooling Technologies Inc. (ACT), a small business based in Lancaster, Pennsylvania, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, designated as a Total Small Business set-aside, supports the development of a psoralen-UV-A irradiation-based high-throughput pathogen inactivation device. The award was issued on July 2, 2025, with an ultimate completion date of...
- The Defense Health Agency awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Safetraces, Inc. on September 15, 2025, for the development of field-deployable environmental biosensing technology to support military readiness through rapid pathogen intelligence. The contract, designated as a total small business set-aside with firm fixed pricing, is scheduled for completion by January 14, 2028, and will be performed at the awardee's facility in Pleasanton,...
- This is a $249,988.57 firm fixed-price Phase I SBIR contract awarded by the Defense Health Agency (DHA) to TDA Research, Inc., a small business based in Colorado. The contract is for the development of a psoralen-UV-A inactivation-based high-throughput pathogen inactivation device. This SBIR contract supports research and development of an innovative medical device technology. TDA Research is an experienced government contractor, holding multiple SBIR and STTR awards as well as other federal...
- The Defense Health Agency awarded a $1.1M Small Business Technology Transfer Phase II contract to CFD Research Corporation for the development of portable phage preparation technology for field application under proposal number A2-9480. The contract, awarded July 3, 2023, with a completion date of May 2, 2026, is structured as a firm fixed-price definitive contract. As a designated small business set-aside award, this STTR Phase II effort builds upon earlier research to advance bacteriophage...
- The Air Force Research Laboratory awarded a $1.24M firm-fixed-price purchase order to Amorphic TECH LTD on February 9, 2024, for the development and delivery of a Personal Modular Purifier for Potable Water. This contract is executed under the Small Business Innovation Research (SBIR) Program Phase II, a federal initiative designed to support small business innovation and advancement in critical technology areas. The award is set aside exclusively for small businesses, and Amorphic TECH LTD, a...
- This is a firm fixed-price, SBIR Phase II contract awarded by the Defense Health Agency (DHA) to Nushores Biosciences LLC, a small business. The contract, valued at $1,299,999.94, is for the product development and commercialization readiness of a class of ether-based bioresorbable polyurethanes for biomedical applications. The contract has a period of performance through December 20, 2026. This award is part of the DHA's SBIR program and is designated as a total small business set-aside.
The Defense Health Agency awarded a $1.95 million Phase II Small Business Innovation Research (SBIR) contract to Puriolabs, LLC on September 5, 2025, for continued development of the Puritall Sterilizer. Under this firm fixed-price definitive contract, the small business concern will execute research and development activities through January 4, 2028, at its facility in Carrollton, Texas. The contract carries a total small business set-aside designation, reserving the opportunity exclusively for small business participation. The Puritall Sterilizer project represents a progression from Phase I validation to Phase II commercialization and prototype refinement within the SBIR program, which funds innovative research and development by small businesses in support of federal agencies' mission requirements. The Defense Health Agency's investment in this sterilization technology reflects the department's interest in advancing healthcare delivery capabilities and operational efficiency across military medical facilities. Puriolabs' receipt of this Phase II award indicates successful completion of initial feasibility studies and demonstration of sufficient technical merit and commercial potential to warrant expanded development funding.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9m | 9/2/25 |